Clinical Trials
17
Trial Phases
3 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (17 trials with phase data)• Click on a phase to view related trials
ICG-Guided Photodynamic Therapy for Treatment of Retinal Capillary Abnormalities: A Pilot Study
- First Posted Date
- 2013-11-01
- Last Posted Date
- 2013-11-01
- Lead Sponsor
- Manhattan Eye, Ear & Throat Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT01974622
- Locations
- 🇺🇸
Vitreous Retina Macula Consultants of New York, New York, New York, United States
Intravitreal Aflibercept Injections In The Treatment Of Pattern Dystrophy
- First Posted Date
- 2013-10-18
- Last Posted Date
- 2014-12-31
- Lead Sponsor
- Manhattan Eye, Ear & Throat Hospital
- Registration Number
- NCT01965041
- Locations
- 🇺🇸
Ns/Lij Meeth, New York, New York, United States
Treatment of Chronic Central Serous Chorioretinopathy With Open-Label Anecortave Acetate
- Conditions
- Chronic Central Serous Chorioretinopathy
- Interventions
- First Posted Date
- 2007-06-21
- Last Posted Date
- 2012-10-25
- Lead Sponsor
- Manhattan Eye, Ear & Throat Hospital
- Target Recruit Count
- 5
- Registration Number
- NCT00489840
- Locations
- 🇺🇸
Manhattan Eye, ear & Throat Institute, New York, New York, United States
🇺🇸Vitreous-Retina-Macula Consultants of New York,PC, New York, New York, United States
Treatment of Exudative and Vasogenic Chorioretinal Diseases Including Variants of AMD and Other CNV Related Maculopathy
- Conditions
- Coats' DiseaseIdiopathic Retinal TelangiectasiaRetinal Angiomatous ProliferationPolypoidal Choroidal VasculopathyPseudoxanthoma ElasticumPathological MyopiaMulti-focal ChoroiditisRubeosis IridisVon Hippel Lindau DiseaseBEST VITELLIFORM MACULAR DYSTROPHY, MULTIFOCAL (Disorder)
- Interventions
- First Posted Date
- 2007-05-08
- Last Posted Date
- 2012-10-25
- Lead Sponsor
- Manhattan Eye, Ear & Throat Hospital
- Target Recruit Count
- 18
- Registration Number
- NCT00470977
- Locations
- 🇺🇸
Lenox Hill Hospital/Manhattan Eye Ear and Throat Institute, New York, New York, United States
🇺🇸Lenox Hill Hospital/Manhattan Eye, Ear & Throat Institute, New York, New York, United States
Treatment of Congenital Telangiectasia (Coat's Disease) With Open-label Anecortave Acetate (15mg.)
- Conditions
- Coat's Disease
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2012-10-24
- Lead Sponsor
- Manhattan Eye, Ear & Throat Hospital
- Target Recruit Count
- 4
- Registration Number
- NCT00211315
- Locations
- 🇺🇸
Manhattan Eye, Ear & Throat Hospital, New York, New York, United States
- Prev
- 1
- 2
- 3
- 4
- Next